Inherited FAT1 mutations affect kidney development and have been linked to clinical glomerulotubular nephropathy (59), while somatic mutations are increasingly recognized in both solid tissue and hematopoietic cancers (27). The gene discussed is FAT1; the disease is hematopoietic and lymphoid cell neoplasm.